Latest research based on animal model trials shows GLP-1 drugs may prevent problem of ‘no-reflow’ in recoveryWeight-loss drugs could help people who have had a heart attack avoid suffering potentially fatal complications afterwards, research has found.Drugs such as Ozempic and Wegovy reduce the risk of the tissue damage that affects up to half of the 100,000 people a year in the UK who suffer a heart attack, according to the study. Continue reading...